(19)

(11)

EP 2 968 573 A1

(12)

(43) Date of publication: 20.01.2016 Bulletin 2016/03 (21) Application number: 14714047.9 (22) Date of filing: 07.03.2014

(51) International Patent Classification (IPC):  A61K 47/10(2006.01) A61K 9/08(2006.01) A61K 47/26(2006.01) A61K 31/167(2006.01) (86) International application number: PCT/US2014/021590 (87) International publication number: WO 2014/149939 (25.09.2014 Gazette 2014/39)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME (30) Priority: 15.03.2013 IN DE07652013 (71) Applicants: NOVARTIS CONSUMER HEALTH, INC. Parsippany, NJ 07054 (US) Novartis Healthcare Private Limited Mumbai 400 018 (IN)	(72) Inventors: BHARATI, Mahesh, Sudhakar Mumbai 400 018 (IN) YARABE, Houphouet, Hyacinthe Parsippany, NJ 07054 (US) (74) Representative: Walker, Ralph Francis et al GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)